Analysis of myosin heavy chain functionality in the heart

Area of Science:

• Biochemistry
• Molecular Biology
• Cardiovascular Research

Background:

• Mammalian cardiac alpha- and beta-myosin heavy chain isoforms share 93% amino acid identity.
• Previous genetic methods achieved only minor myosin isoform switches in mammalian hearts.
• Cardiac-specific transgenesis enables significant myosin isoform shifts and replacements.

Purpose of the Study:

• To investigate the structural basis of mammalian cardiac myosin isoform diversity.
• To determine the role of surface loops 1 and 2 in myosin isoform-specific characteristics.
• To engineer alpha- to beta-myosin isoform switches in mouse hearts and analyze functional consequences.

Main Methods:

• Cardiac-specific transgenesis was used to create mouse models with engineered myosin isoform switches.
• Chimeric myosins were constructed by exchanging sequences of Loop 1+Loop 2 or Loop 2 between alpha- and beta-myosin.
• In vivo expression of chimeric myosins was performed to assess their functional properties.

Main Results:

• Significant differences in filament sliding velocity and ATPase activity were observed between native alpha- and beta-myosin isoforms.
• Engineered chimeric myosins (Loop 1+Loop 2 and Loop 2 exchanges) did not show significant alterations in filament sliding velocity or ATPase activity compared to alpha-myosin.
• Myosin functionality in mouse cardiac isoforms is not dependent on Loop 1 or Loop 2 sequences.

Conclusions:

• The functional differences between mammalian cardiac alpha- and beta-myosin heavy chain isoforms do not reside in Loop 1 or Loop 2.
• Myosin functionality is likely influenced by other non-homologous residues not examined in this study.
• This research provides insights into the structural determinants of myosin isoform function in the heart.